From Farm to Pharmacy: ICMR and ICAR Launch ‘SEHAT’ to Revolutionize India’s Public Health through Agricultural Innovation

Date:

Share post:

In a landmark initiative to bridge the gap between agriculture and public health, the Indian Council of Medical Research (ICMR) and the Indian Council of Agricultural Research (ICAR) jointly launched “SEHAT” (Science Excellence for Health through Agricultural Transformation). This national mission-mode program aims to translate agricultural advancements into tangible health outcomes, marking a shift from curative to preventive healthcare.

Unveiled by Union Health Minister Shri J.P. Nadda and Union Agriculture Minister Shri Shivraj Singh Chouhan, the mission addresses India’s dual burden of persistent malnutrition and rising non-communicable diseases (NCDs) like diabetes and cancer. Shri Nadda emphasized that SEHAT embodies a “whole-of-government” approach, integrating science and policy to ensure that agricultural solutions meet emerging health challenges.

The mission prioritizes on developing nutrient-dense varieties to eliminate micronutrient deficiencies. It  promotes dietary diversification and boosting farm resilience and addressing specific health risks faced by agricultural workers. It focues on leveraging functional foods and superior crop varieties to manage lifestyle diseases and strengthening surveillance and research at the human-animal-environment interface.

Shri Chouhan remarked that with this scientific validation, “food can become medicine,” aligning agricultural production directly with the population’s nutritional needs. Dr. Rajiv Bahl, DG ICMR, added that the initiative will generate a data-driven framework to inform future policy interventions.

By leveraging agricultural transformation as a determinant of health, SEHAT aims to pave the way for a healthier, stronger, and more self-reliant India.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...